KAKKIS EMIL D

RARE

KAKKIS EMIL D serves as President & CEO at Ultragenyx Pharmaceutical Inc. (RARE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

10 trades

$15.70M

Net Position

Net Seller

$15.70M

Companies Traded

RARE

Active Period

May 2021 – Feb 2025

10 total trades

Most Recent

Sell RARE

Feb 28, 2025 · $4.15M

KAKKIS EMIL D's Insider Trading at Ultragenyx Pharmaceutical Inc. (RARE)

Buys

0 · $0.00

Sells

10 · $15.70M

Total Shares Bought

Total Shares Sold

315,869

RARE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 28, 2025	Sell	98,434	$42.20	$4.15M	0
Dec 31, 2024	Sell	11,727	$42.23	$495.2K	2,183,985
Dec 11, 2024	Sell	8,273	$50.00	$413.6K	2,195,712
Sep 5, 2024	Sell	20,000	$55.85	$1.12M	2,223,985
Aug 7, 2024	Sell	20,000	$50.17	$1.00M	2,243,985
Feb 8, 2024	Sell	30,000	$45.00	$1.35M	539,770
Jan 2, 2024	Sell	30,000	$47.87	$1.44M	569,770
Oct 23, 2023	Sell	47,853	$33.52	$1.60M	599,743
Jan 3, 2023	Sell	19,582	$45.57	$892.4K	541,108
May 5, 2021	Sell	30,000	$107.80	$3.23M	2,259,741

Related Insiders

Howard Horn

officer: Chief Financial Officer

RARESell · Apr 2, 2026

Karah Herdman Parschauer

officer: EVP and Chief Legal Officer

RARESell · Mar 10, 2026

Explore More Insider Trading Data

RARE Insider Trading Activity

View all insider trades at Ultragenyx Pharmaceutical Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity